After a research breakthrough in Parkinson’s treatment, Argenica have reinforced the potential of ARG-007 to treat a range of neurological issues.
To learn about investment opportunities with Altech Batteries, receive up-to-date information directly from the company’s Chief Financial Officer, Mr. Martin…
A deepened relationship with IBM and a new alliance with Fuseforward brings a new skill set and ESG focused technology to West Australian industry.
With potential to treat a range of brain issues, Argenica is advancing ARG-007 to stage 2 stroke trials with some of Australia’s eminent experts.
Shown to produce half the emissions of lithium-ion batteries, Altech is proving up its green credentials as it brings its eco-friendly facility online.
Ubaryon receive a five-year permit renewal on novel uranium enrichment technology as global powers continue to turn towards nuclear.
Altech assemble a remarkable group of experts to bring their designs to a German battery facility which could disrupt the lithium-ion industry.
Preclinical trials on a rat model show Argenica’s novel therapeutic for stroke patients significantly reduces brain cell damage.
Would be robotic deliverers Zume Pizza is liquidating their assets as a number of other players try to crack the value of robot pizza.
Frugl strike an accord to bring its health tech to a prominent United Arab Emirates retailer about to embark on a dynamic growth phase.